Chlamydia and mycoplasma is the most common pathogens of non bacterial prostatitis, epididymitis ,and non gonococcal urethritis.

Chlamydia and Mycoplasma Infection

Chlamydia and mycoplasma are common sexually transmitted disease (STD) caused by the chlamydia trachomatis and ureaplasma urealyticum . Chlamydia and mycoplasma can damage the reproductive system in both men and women. Although symptoms of chlamydia and mycoplasma can be mild or absent, serious complications causing irreversible damage, including infertility, can occur before an infected person realizes the problem.

Chlamydia and mycoplasma can be transmitted during vaginal, anal, and oral sex. They can be passed from an infected mother to her baby during vaginal childbirth. Any sexually active person can be infected with chlamydia and mycoplasma. And, the greater the number of sex partners a person has (or had), the greater the risk of infection.

       

Most unfortunate is the ability of chlamydia and mycoplasma to hide itself deep inside the genitourinary tract making it very difficult to detect by urethral swabbing and urine analysis; two commonly used sample collection methods for chlamydia and mycoplasma testing in clinical practice. Thus, many urologists and STD doctors are unable to identify chlamydia and mycoplasma as a causative pathogen. As a result, they often make general diagnosis, such as, non-specific urethritis, prostatitis, and/or pelvic inflammatory disease (PID), etc. And, they frequently prescribe a variety of ineffective broad-spectrum antibiotics making the patient condition more complicated; weakening the immune system, causing antibiotic resistance, failing to address causative pathogens, and allowing the infection to spread, etc.

Chlamydia and Mycoplasma Pathogencity

Chlamydia and mycoplasma are prokaryot intracellular parasite; a microorganism, which are different from a common bacteria or virus. The prokaryotes are a group of organisms that lack a cell nucleus or any other membrane-bound organelles. Chlamydia and mycoplasma , unlike other bacteria, differs in the way it synthesizes energy. Bacteria usually synthesize energy by Adenosine Triphosphate (ATP); a general way of synthesizing energy by living cells. However, Chlamydia and mycoplasma synthesizes energy directly from the infected host cells; it suppresses the metabolism and dissolves the cells. Overtime, the cells are destroyed, the infected person immune system is weakened, and the infection spreads.

Chlamydia and mycoplasma are known as the silent disease because the majority of infected people have no symptoms during the early stages of infection. When symptoms are noticed, complications have usually occurred. These complications include: urethritis, prostatitis, epididymitis, and infertility, etc. (in men); and pelvic inflammatory disease (PID), ectopic pregnancy, and infertility, etc. (in women). Chlamydia and mycoplasma can also cause blindness, junctivitis, arthritis, pneumonia, bronchitis, and lymphogranuloma venereum (LGV), etc.

Chronic genitourinary tract chlamydia and mycoplasma infections often result in complications. Prostate tubes, spermatic ducts, epididymal ducts, ejaculatory ducts, and ovarian ducts become blocked. Overtime scarring, calcification, and irreversible damage occur. Once this happens, antibiotics cannot reach the blocked and scared areas making chlamydia and mycoplasma very difficult to cure.

Chlamydia and mycoplasma Symptoms

At the early stage of chlamydia and mycoplasma infection, most of patients have no symptoms. Symptoms may appear 1 to 3 weeks and months later when complications emerge.

For men, genitourinary chlamydia and mycoplasma infections usually start in the anterior urethra, then move to the posterior urethra, prostate, seminal vesicles, spermatic ducts, and epididymis. The complications include:

1) At the early stage of chlamydia and mycoplasma infection, some patients may have urethritis within 1 to 4 weeks. Common symptoms include: itching, pain, and burning during urination; pus, watery, and milky discharge from the penis; and frequent urination.

2) In the chronic stage of chlamydia and mycoplasma infection, complications of the prostate usually occur. Common symptoms include: pain, tension, and discomfort in perineal area; pain around the anus; sexual function disorder; pain in the prostate; enlarged and inflamed prostate; weak urine flow, and/or frequent night urination; epididymitis; pain or tenderness in testicles; thickening of the spermatic ducts; poor semen quality; blockage and calcification; and infertility, etc.

3) Other chlamydia and mycoplasma symptoms include: seminal vesiculitis; change in semen color, yellowish and bloody semen, decrease in semen volume, and pain during and after ejaculation; and pain or discomfort in the butt or thighs. Patients who engage in anal sex may have rectitis. Patients who engage in oral sex may have pharyngolaryngitis and pneumoniae. Few patients may develop Reiter Syndrome; arthritis, conjunctivitis, and urethritis at the same time.

For women with genitourinary chlamydia and mycoplasma infections

1) The most common place of chlamydia and mycoplasma infection is the cervix causing cervicitis; inflammation of the uterine cervix. Common symptoms include: painful intercourse, abnormal vaginal discharge (a yellowish discharge from the cervix that may have a strong odor), cervix erosion, vaginal bleeding after intercourse, and cervix congestion, etc. Abnormal vaginal discharge may affect the urethra causing urethritis; pain or burning while urinating, frequent urination, and the urge to urinate more than usual.

The infection in the cervix will spread to the ovarian ducts and other organs causing endometritis, salpingitis, and pelvic inflammatory disease (PID), etc. Common symptoms include: abdominal pain, pain in the lower back, low fever, irregular menstruation, and bleeding between menstrual periods, spontaneous abortion, extrauterine pregnancy, blocked fallopian tubes, and infertility, etc.

Chlamydia and Mycoplasma and Infertility

Research indicates that among patients who have infertility, about 50% to 60% of them are positive for chlamydia and/or mycoplasma. We believe the infection rate is higher. We find that most of our patients have active pathogen infections (see laboratory testing). chlamydia and mycoplasma are the major cause of ectopic pregnancy and infertility in Western countries. Our research indicates most patients suffering from infertility because of active causative pathogens.

Chlamydia and mycoplasma are common sexually transmitted pathogens found in genitourinary infections. They can cause prostatitis and epididymitis in males, and cervicitis and pelvic inflammatory disease PID in females. These, infectious pathogens alter and damage the inner reproductive systems. They cause infertility, miscarriage, and/or the birth of unhealthy children, etc.

Chlamydia and mycoplasma Lab Testing

Currently, in clinical practice there are several standard chlamydia and mycoplasma test methods available to check for chlamydia and mycoplasma genitourinary infection. However, most of these tests often give inaccurate results. One such widely used chlamydia and mycoplasma test is the rapid screening (colloidal gold) method in which urine and urethral swabs are used in sample collection. We found this method gives inaccurate chlamydia and mycoplasma test results.

Since chlamydia and mycoplasma lives inside epithelia cells, it is difficult to obtain accurate chlamydia and mycoplasma test results because these methods require tissue samples to be collected from the infected areas. In the chronic chlamydia and mycoplasma infection stage, chlamydia and mycoplasma tends to hide inside tissues located deep within the genitourinary system. The locations of the chlamydia and mycoplasma infection make it difficult to collect qualified samples. Thus, it is hard to obtain accurate chlamydia and mycoplasma test results using standard chlamydia and mycoplasma test methods.

In our clinical research, we have found the most accurate chlamydia and mycoplasma test methods for genitourinary chlamydia and mycoplasma infection are the following:

1) For acute chlamydia and mycoplasma urinary or cervix infection with inflammatory discharge: urethral swab and/or cervix swab, and swab of the infected areas for the antigen of chlamydia and mycoplasma using the PCR test.

2)For chronic chlamydia and mycoplasma infection and complications: blood serum for the IgM antibody of chlamydia using the ELISA test,semen and inflammatory secretion culture for mycoplasma.Male patients who have pain in the testicles, and female patients who have pain in the pelvic area, should have these tests performed. Patients should go to an advanced laboratory to have this chlamydia and mycoplasma test done.

Treatment for Chlamydia and Mycoplasma

Conventional medical knowledge suggests that chlamydia and mycoplasma can easily be cured. Treatment guidelines for sexually transmitted disease (STD) recommend taking oral antibiotics for one week or less to treat chlamydia and mycoplasma infections. We do not agree.

For a patient who has an acute chlamydia and mycoplasma urinary tract infection, taking oral antibiotics for short periods (less than two weeks) will most likely only control the reproduction of chlamydia and mycoplasma and suppress the symptoms. This type of treatment will usually not kill the infection. Patients often relapse, symptoms reemerge, and complications occur. For acute chlamydia and mycoplasma genitourinary tract infections, we recommend taking oral antibiotics for at least two weeks. Heavy dosages and/or broad-spectrum antibiotics should be avoided. These will cause bacteria imbalance, antibiotic resistance, and other side effects. We recommend taking azithromycin and doxycycline, and to avoid alcohol, and sexual activity during treatment.

For chronic chlamydia and mycoplasma genitourinary tract infections and the resulting complications, oral antibiotics will not kill the infection because the medicine cannot penetrate the infected and blocked areas in high enough concentrations. The infected areas are often located deep inside the genitourinary tract. For chronic patients who relapse with oral antibiotic treatments, we recommend our 3D Targeted Treatment. We have successfully treated many patients, both male and female, with deep genitourinary tract chlamydia and mycoplasma infections using our 3D Targeted Treatment.

3D Targeted Treatment - How We Cure Chlamydia and Mycoplasma

We collect tissue samples from infected surfaces and fluid samples from deep tissue areas. We use the International Standard Test Method (ELISA and Culture) to detect chlamydia and mycoplasma accurately. We analyze the test results and combine with the patient symptoms, physical examination, and our extensive clinical experience to locate and treat the infected areas.

Chlamydia and mycoplasma infections, that cause only non gonococcal urethritis, and cervicitis can often be completely cured within 2 weeks of 3D Targeted Treatment.

Chlamydia and mycoplasma infections,that cause prostatitis, epididymitis, pelvic inflammatory disease, and/or infertility can often be completely cured within 4 weeks of 3D Targeted Treatment.

Our exclusive 3D Targeted Treatment allows the medicine to work in the infected areas located deep within the genitourinary tract at high concentrations. Our proprietary 3D chlamydia and mycoplasma targeted treatment is superior to all other treatments currently available for the eradication of chlamydia and mycoplasma rooted deep in the genitourinary system, and for clearing blockage and toxic residue. Since 1994, we have treated thousands of patients with chlamydia and mycoplasma infections.Over the last 20 years, our cure rate for treating chlamydia,mycoplasma and gonococcus infection is 100%.

3D Targeted Treament-Chlamydia and Mycoplasma Cure Clinical Cases

Most male patients with chlamydia and mycoplasma genitourinary tract infections who receive our 3D Targeted Treatment have prostrate complications (prostratitis). At least 30% of these infected people tested negative for chlamydia and mycoplasma prior to arriving at our clinic. When they arrived, we tested them and found them to be positive for chlamydia and mycoplasma (infected).

Case I- simple urinary infection

Patient: Mr. Chen

Symptoms: Itching, pain, and burning in the urethra, and small amount of yellowish discharge in the morning. Symptoms appeared three weeks after having unprotected sex.

Previous Treatment: IV with antibiotics for 12 days (failed), and he developed resistant to antibiotics.

Previous Test: Chlamydia and mycoplasma positive

Our Test Result: Chlamydia and mycoplasma positive

3D Targeted Treatment: After one week of 3D Targeted Treatment all symptoms disappeared. A retest for chlamydia and mycoplasma , result was negative.

Case II- Combined with epididymitis and prostatitis

Patient: Chris

Symptoms: Had symptoms for 4 years, testicle pain started one month after having anal sex, the pain spread to the groin area. Months later, pain in perineal area and frequent urination at night.

Previous treatment: Tried many kinds of oral antibiotics without success.

Previous Test: Chlamydia negative.

Our test result: Chlamydia positive.

3D Targeted Treatment: After 28 days of 3D Targeted Treatment, most of the symptoms disappeared. The retest for chlamydia was negative.

Case III- Combined with epididymitis, prostatitis and infertility

Patient: Mr. Wang

Symptoms: Had symptoms for 5 years, pain in the perineal area, pain in the testicles, pain in the groin area, and discomfort around the anus. Married for two years, however his wife could not become pregnant.

Previous Treatment: Many different types of oral antibiotics and herbal treatments for two years without success.

Previous Test: Found Staphylococcus Aureus, Chlamydia and mycoplasma negative.

Our Test Results: Staphylococcus Aureus positive, Chlamydia and mycoplasma positive, poor semen quality, and his wife tested positive for Chlamydia and mycoplasma .

3D Targeted Treatment: After 30 days of 3D Targeted Treatment his symptoms disappeared. He was rechecked for staphylococcus aureus and chlamydia and mycoplasma , both negative. His wife received 15 days of 3D Targeted Treatment and her chlamydia and mycoplasma turned negative. Six months after the 3D Targeted Treatment his wife became pregnant and their child is very healthy.

Case IV- Combined with prostatitis, arthritis, and pneumonia

Patient: Milo

Symptoms: Had symptoms for three years, pain in the groin area, pain in the perineal area, pain in the knees, and chest pressure and cough.

Previous Treatment: Many different types of oral antibiotics.

Previous Test: Streptococcus positive, chlamydia negative.

Our Test Result: Corynebcaterium positive, chlamydia positive.

3D Targeted Treatment: After 30 days of 3D Targeted Treatment symptoms almost disappeared. Retested for corynebcaterium and chlamydia, all negative.